Koteish Ayman, Thuluvath Paul J
Department of Medicine, Johns Hopkins University School of Medicine, 1830 Monument Street, Room 429, Building 1830, Baltimore, MD 21025, USA.
J Vasc Interv Radiol. 2002 Sep;13(9 Pt 2):S185-90. doi: 10.1016/s1051-0443(07)61785-0.
To determine the role of screening and to screen in a cost-effective manner, it is important to define the high-risk patient population that is most likely to benefit from screening and to identify a readily available diagnostic modality that is sensitive, specific, and inexpensive. Moreover, to have a major effect on the outcome of hepatocellular carcinoma, the test should be applicable in the majority of high-risk subjects. Herein, we identify the high-risk patient population, discuss various diagnostic modalities, and recommend a practical and cost-effective strategy for screening.
为了确定筛查的作用并以具有成本效益的方式进行筛查，重要的是定义最有可能从筛查中受益的高危患者群体，并确定一种易于获得、敏感、特异且廉价的诊断方法。此外，为了对肝细胞癌的治疗结果产生重大影响，该检测应适用于大多数高危受试者。在此，我们确定高危患者群体，讨论各种诊断方法，并推荐一种实用且具有成本效益的筛查策略。
